These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1282702)

  • 21. Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex.
    Battiste JL; Mao H; Rao NS; Tan R; Muhandiram DR; Kay LE; Frankel AD; Williamson JR
    Science; 1996 Sep; 273(5281):1547-51. PubMed ID: 8703216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein.
    Jensen KB; Green L; MacDougal-Waugh S; Tuerk C
    J Mol Biol; 1994 Jan; 235(1):237-47. PubMed ID: 8289245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.
    Bartel DP; Zapp ML; Green MR; Szostak JW
    Cell; 1991 Nov; 67(3):529-36. PubMed ID: 1934059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
    DeJong ES; Chang CE; Gilson MK; Marino JP
    Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides.
    Chin DJ
    J Virol; 1992 Jan; 66(1):600-7. PubMed ID: 1727504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability.
    Hung LW; Holbrook EL; Holbrook SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5107-12. PubMed ID: 10792052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region.
    Heaphy S; Dingwall C; Ernberg I; Gait MJ; Green SM; Karn J; Lowe AD; Singh M; Skinner MA
    Cell; 1990 Feb; 60(4):685-93. PubMed ID: 1689218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA tertiary structure of the HIV RRE domain II containing non-Watson-Crick base pairs GG and GA: molecular modeling studies.
    Le SY; Pattabiraman N; Maizel JV
    Nucleic Acids Res; 1994 Sep; 22(19):3966-76. PubMed ID: 7937119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands.
    Jensen KB; Atkinson BL; Willis MC; Koch TH; Gold L
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12220-4. PubMed ID: 8618873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molding a peptide into an RNA site by in vivo peptide evolution.
    Harada K; Martin SS; Tan R; Frankel AD
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element.
    Daly TJ; Doten RC; Rennert P; Auer M; Jaksche H; Donner A; Fisk G; Rusche JR
    Biochemistry; 1993 Oct; 32(39):10497-505. PubMed ID: 8399195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A three-dimensional model of the Rev-binding element of HIV-1 derived from analyses of aptamers.
    Leclerc F; Cedergren R; Ellington AD
    Nat Struct Biol; 1994 May; 1(5):293-300. PubMed ID: 7664035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction with the Rev response element along an extended stem I duplex structure is required to complete human immunodeficiency virus type 1 rev-mediated trans-activation in vivo.
    Kimura T; Ohyama A
    J Biochem; 1994 May; 115(5):945-52. PubMed ID: 7961610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE.
    Powell DM; Zhang MJ; Konings DA; Wingfield PT; Stahl SJ; Dayton ET; Dayton AI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):317-23. PubMed ID: 7552493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.